Neurology
Motor Neurone Disease: Investigating if specific toxins contribute towards to the onset of MND
Research Objectives
Status
Completed
Recruitment
Closed
Study location
Wesley Research Institute, The University of Queensland
Study type
Investigator Initiated
Lead investigator
- Prof Pamela McCombe (UQ)
Experienced investigator
- Dr Aven Lee (UQ)
About this research project
Motor neurone disease (MND) is a severe disease for which there is no successful therapy. Currently there is no cure for MND. The best approach in clinical practice is primary prevention through the modification of risk factors.
In a novel study previously funded by Wesley Research Institute, we have demonstrated that MND patients have increased levels of homocysteine sulfinic acid, an excitotoxin that can be produced by the gut microbiota.
In this follow up study, we will investigate if the increases in these excitotoxins change during disease progression and correlate with survival. These toxins could contribute to the onset of MND. It’s possible that eliminating these gut toxins could lead to better patient outcomes.
Latest News
Coeliac Disease Myths vs Facts
In this article, we separate myth from fact and explore more about coeliac disease, including who should be tested, why first-degree relatives are at greater risk, what a gluten-free diet really involves, and why symptoms don't always fit the textbook description.
Spotlight on Clinical Trial Coordinator Chris: Making Every Patient Experience Count
Behind every clinical trial is a team dedicated to improving patient outcomes, and Chris is one of the people at the heart of that mission.
Why Do We Need Treatments Beyond the Gluten-Free Diet for Coeliac Disease?
While a gluten-free diet (GFD) is the cornerstone of coeliac disease management, it is not a perfect solution. This blog explores the limitations of the gluten-free diet and why additional treatments are necessary to improve long-term health outcomes for people with coeliac disease.